MLchartDataset catalogue

Turalio

Term · Oncology and biomedicine · MLC-T-ONC-008988

A drug used to treat adults with tenosynovial giant cell tumor (a rare, usually benign tumor that affects the joints). It is used in patients who have a severe form of the disease that is not likely to get better with surgery. It is also being studied in the treatment of some types of cancer and other conditions. Turalio blocks certain proteins, which may help keep tumor cells from growing and spreading. It is a type of tyrosine kinase inhibitor. Also called pexidartinib hydrochloride.

Table 1. Record
IdentifierMLC-T-ONC-008988
FieldOncology and biomedicine
Synonymspexidartinib hydrochloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008988",
  "term": "Turalio",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with tenosynovial giant cell tumor (a rare, usually benign tumor that affects the joints). It is used in patients who have a severe form of the disease that is not likely to get better with surgery. It is also being studied in the treatment of some types of cancer and other conditions. Turalio blocks certain proteins, which may help keep tumor cells from growing and spreading. It is a type of tyrosine kinase inhibitor. Also called pexidartinib hydrochloride.",
  "synonyms": [
    "pexidartinib hydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/turalio/"
}

Record 16,849 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.